Lilly's lepodisiran shows a 94% reduction in heart disease risk by lowering lipoprotein(a) levels, offering a breakthrough in cardiovascular innovation.

BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...

A Kalamazoo Township police officer and a suspect were hurt after shots were fired in Kalamazoo on Thursday, according to the ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein (a) levels by more than 90% for at least six ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

Franklin Township police were notified that contact was lost with a plane somewhere over the township after it took off from ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

Eli Lilly (LLY) and Company announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA, siRNA, therapy ...

Crimson photographers traveled across the globe during the College’s spring break last week, documenting scenes from vibrant ...

EdTech technology start-ups are being urged to apply to the second year of the successful EdTech Accelerator Programme run by ...

Today's riddle: What do you call a giraffe in the middle of the road? 🤔 (Answer below!) Weather forecast: 🗓 Upcoming Events ...